Background Image

Board of Directors

aq_block_5

CURT CETRULO, MD

President, Board of Directors


Curtis L. Cetrulo, Jr., M.D., FACS, FAAP is the Senior Investigator and Head of the Vascularized Composite Allotransplantation Laboratory at the Transplantation Biology Research Center (TBRC) at Massachusetts General Hospital (MGH). Dr. Cetrulo graduated from Stanford University and Tufts University School of Medicine with Honors in Research. Dr. Cetrulo joined the Division of Plastic Surgery of the Massachusetts General Hospital and the staff of Shriners Hospital for Children-Boston. He helped to lead many of the groundbreaking large animal trials that prove the effectiveness of xeno-skin.

aq_block_10

WILLIAM DEACON

Vice President, Board of Directors


Bill Deacon is a qualified Portfolio Advisor who, in addition to providing traditional advice and guidance, can help clients pursue their investment objectives by recommending individual, or any combination of, Merrill Lynch or approved third-party investment managers' strategies, funds, or portfolios. His approach to wealth management focuses on building long-lasting relationships with clients in order to understand their goals and objectives. Before making financial recommendations, he conducts a financial profile in order to understand each client’s needs and intentions in order to provide a customized investment approach to meet their needs.
Bill provides a high level of personal service and guides clients through the investment process which includes cash flow, retirement, education and estate planning strategies, and liability/debt management. Bill and his team are committed to providing outstanding service and communication with each client.

aq_block_13

MICHAEL YAREMCHUK, MD

Board Director


Dr. Yaremchuk is the Program Director of the Harvard Plastic Surgery Residency Program, Director of Craniofacial Surgery at MGH, and a Clinical Professor of Surgery at the Harvard Medical School. He received his M.D. from the Columbia College of Physicians and Surgeons, and his B.A. from Yale College.
Dr. Yaremchuk practices a full range of plastic surgery including facial and eyelid rejuvenation, facial implant surgery and rhinoplasty. Patients who are unhappy with prior cosmetic surgery are routinely referred to him for correction. As a craniofacial surgeon, Dr. Yaremchuk has a special interest in aesthetic and reconstructive surgery of the face and facial skeleton. He is recognized for his treatment of post-traumatic facial deformities as well as post-orthognathic imbalances and irregularities. Recent international speaking engagements addressing craniofacial and aesthetic topics include those in Korea, Japan, Germany, Brazil, Russia and China.

aq_block_15

DAVID H. SACHS, M.D.

Board Director


David H. Sachs, M.D. specializes in transplantation medicine and immune tolerance and is an expert in xenotransplantation. Dr. Sachs’ many research achievements include the discovery of Ia (Class II) antigens and the development of monoclonal antibodies to MHC antigens. He served at the National Institutes of Health in Bethesda, where he later became the Chief of the Immunology Branch, National Cancer Institute. Dr. Sachs is a Director of the Transplantation Biology Research Center, Surgical services at Massachusetts General Hospital, and is the first Paul S. Russell and Warner-Lambert Professor of Surgery and Immunology at the Harvard Medical School. Dr. Sachs was elected to the Institute of Medicine of the National Academy of Sciences in 1996. During a sabbatical year, he was a Visiting Professor, Department of Cell Research, Wallenberg Laboratory at the University Of Uppsala, where he initiated studies of the molecular biology of transplantation antigens. Dr. Sachs subsequently returned to Massachusetts General Hospital and Harvard Medical School in his current positions. He has published over 650 articles in scientific journals. Dr. Sachs is a Member of the Editorial Board of several journals in his field. He has received many honors and awards including the Award for Distinguished Contributions to Health Research by The Medical Foundation in 2001, the Mary Jane Kugel Award by the Juvenile Diabetes Research Foundation, the Jean Borel Award in Transplantation, and the ASTP/Novartis Established Investigator Award in 1998, the AST Distinguished Achievement Award (2005), the Martin Prize for Excellence in Clinical Research in 2009, and the Thomas E. Starzl Prize in Surgery and Immunology in 2012. Dr. Sachs trained as a Surgical Intern and Research Fellow in Transplantation at the Massachusetts General Hospital. He received an M.D., magna cum laude, from Harvard Medical School, graduated from Harvard College, summa cum laude, with an A.B. in Chemistry, and received a Diplome d'Etudes Superieures de Sciences in Organic Chemistry from the University of Paris the following year where he studied as a Fulbright fellow.